616 related articles for article (PubMed ID: 32442144)
1. Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.
Hankins JS; Shah N; DiMartino L; Brambilla D; Fernandez ME; Gibson RW; Gordeuk VR; Lottenberg R; Kutlar A; Melvin C; Simon J; Wun T; Treadwell M; Calhoun C; Baumann A; Potter MB; Klesges L; Bosworth H;
JMIR Res Protoc; 2020 Jul; 9(7):e16319. PubMed ID: 32442144
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study.
Badawy SM; DiMartino L; Brambilla D; Klesges L; Baumann A; Burns E; DeMartino T; Jacobs S; Khan H; Nwosu C; Shah N; Hankins JS;
JMIR Form Res; 2022 Oct; 6(10):e41415. PubMed ID: 36240004
[TBL] [Abstract][Full Text] [Related]
3. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
[TBL] [Abstract][Full Text] [Related]
4. A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Hankins JS; Brambilla D; Potter MB; Kutlar A; Gibson R; King AA; Baumann AA; Melvin C; Gordeuk VR; Hsu LL; Nwosu C; Porter JS; Alberts NM; Badawy SM; Simon J; Glassberg JA; Lottenberg R; DiMartino L; Jacobs S; Fernandez ME; Bosworth HB; Klesges LM; Shah N
Blood Adv; 2023 Dec; 7(23):7190-7201. PubMed ID: 37738155
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease.
Hankins JS; Potter MB; Fernandez ME; Melvin C; DiMartino L; Jacobs SR; Bosworth HB; King AA; Simon J; Glassberg JA; Kutlar A; Gordeuk VR; Shah N; Baumann AA; Klesges LM;
Front Health Serv; 2022; 2():1024541. PubMed ID: 36925803
[TBL] [Abstract][Full Text] [Related]
6. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study.
Creary S; Chisolm D; Stanek J; Hankins J; O'Brien SH
JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13452. PubMed ID: 31397291
[TBL] [Abstract][Full Text] [Related]
7. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
Luo L; King AA; Carroll Y; Baumann AA; Brambilla D; Carpenter CR; Colla J; Gibson RW; Gollan S; Hall G; Klesges L; Kutlar A; Lyon M; Melvin CL; Norell S; Mueller M; Potter MB; Richesson R; Richardson LD; Ryan G; Siewny L; Treadwell M; Zun L; Armstrong-Brown J; Cox L; Tanabe P
JMIR Res Protoc; 2021 Apr; 10(4):e24818. PubMed ID: 33861209
[TBL] [Abstract][Full Text] [Related]
8. Recruitment Strategies in the Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization Study (meSH): Multicenter Survey Study.
Nwosu C; Khan H; Masese R; Nocek JM; Gollan S; Varughese T; Bourne S; Clesca C; Jacobs SR; Baumann A; Klesges LM; Shah N; Hankins JS; Smeltzer MP
JMIR Form Res; 2024 Apr; 8():e48767. PubMed ID: 38625729
[TBL] [Abstract][Full Text] [Related]
9. Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study.
Badawy SM; Abebe KZ; Reichman CA; Checo G; Hamm ME; Stinson J; Lalloo C; Carroll P; Saraf SL; Gordeuk VR; Desai P; Shah N; Liles D; Trimnell C; Jonassaint CR
JMIR Res Protoc; 2021 May; 10(5):e29014. PubMed ID: 33988517
[TBL] [Abstract][Full Text] [Related]
10. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial.
Sekandi JN; Onuoha NA; Buregyeya E; Zalwango S; Kaggwa PE; Nakkonde D; Kakaire R; Atuyambe L; Whalen CC; Dobbin KK
JMIR Res Protoc; 2021 Jan; 10(1):e18029. PubMed ID: 32990629
[TBL] [Abstract][Full Text] [Related]
11. ENHANCE-(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease.
Creary S; Chisolm DJ; O'Brien SH
JMIR Res Protoc; 2016 Oct; 5(4):e193. PubMed ID: 27697749
[TBL] [Abstract][Full Text] [Related]
12. HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol.
Smaldone A; Manwani D; Aygun B; Smith-Whitley K; Jia H; Bruzzese JM; Findley S; Massei J; Green NS
BMC Pediatr; 2019 Oct; 19(1):354. PubMed ID: 31615480
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of a Web-Based Platform (Trial My App) to Efficiently Conduct Randomized Controlled Trials of mHealth Apps For Patients With Cardiovascular Risk Factors: Protocol For Evaluating an mHealth App for Hypertension.
Lokker C; Jezrawi R; Gabizon I; Varughese J; Brown M; Trottier D; Alvarez E; Schwalm JD; McGillion M; Ma J; Bhagirath V
JMIR Res Protoc; 2021 Feb; 10(2):e26155. PubMed ID: 33522978
[TBL] [Abstract][Full Text] [Related]
14. Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.
Smaldone A; Findley S; Bakken S; Matiz LA; Rosenthal SL; Jia H; Matos S; Manwani D; Green NS
Contemp Clin Trials; 2016 Jul; 49():134-42. PubMed ID: 27327779
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania.
Makubi A; Sasi P; Ngaeje M; Novelli EM; Mmbando BP; Gladwin MT; Makani J
BMC Med Res Methodol; 2016 Oct; 16(1):140. PubMed ID: 27756209
[TBL] [Abstract][Full Text] [Related]
16. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.
Hodges JR; Phillips SM; Norell S; Nwosu C; Khan H; Luo L; Badawy SM; King A; Tanabe P; Treadwell M; Rojas Smith L; Calhoun C; Hankins JS; Porter J
Blood Adv; 2020 Sep; 4(18):4463-4473. PubMed ID: 32941646
[TBL] [Abstract][Full Text] [Related]
17. Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial.
Iribarren S; Milligan H; Goodwin K; Aguilar Vidrio OA; Chirico C; Telles H; Morelli D; Lutz B; Sprecher J; Rubinstein F
JMIR Res Protoc; 2021 Jun; 10(6):e28094. PubMed ID: 34152281
[TBL] [Abstract][Full Text] [Related]
18. Adherence to Hydroxyurea and Patients' Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study.
Madkhali MA; Abusageah F; Hakami F; Zogel B; Hakami KM; Alfaifi S; Alhazmi E; Zaalah S; Trabi S; Alhazmi AH; Mohrag M; Malhan H
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256385
[No Abstract] [Full Text] [Related]
19. Combining Behavioral Economics-Based Incentives With the Anchoring Strategy: Protocol for a Randomized Controlled Trial.
Stecher C; Cloonan S; Linnemayr S; Huberty J
JMIR Res Protoc; 2023 Apr; 12():e39930. PubMed ID: 37115610
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Feasibility, Acceptability, and Efficacy of a Clinical Pharmacist-led Mobile Approach (BPTrack) to Hypertension Management: Mixed Methods Pilot Study.
Buis LR; Roberson DN; Kadri R; Rockey NG; Plegue MA; Danak SU; Guetterman TC; Johnson MG; Choe HM; Richardson CR
J Med Internet Res; 2020 Aug; 22(8):e19882. PubMed ID: 32780026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
